Phil Noland Roberts

Insider Reports History

Location
Exton, PA
Signature
/s/ Sandra Stoneman, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phil Noland Roberts:

Company Role Class Num Shares Value Price $ Report Date Ownership
Immunome Inc. Chief Technology Officer Stock option (right to buy) 275,000 13 Dec 2023 Direct

Insider Reports Filed by Phil Noland Roberts

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMNM Immunome Inc. 13 Dec 2023 1 $0 4 Chief Technology Officer 15 Dec 2023, 19:28
IMNM Immunome Inc. 08 Dec 2023 0 $0 3 Chief Technology Officer 15 Dec 2023, 19:24